Review



fragment libraries for massively parallel sequencing  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Illumina Inc fragment libraries for massively parallel sequencing
    Fragment Libraries For Massively Parallel Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/illumina+short+fragment+sequencing/pm40644351-56-0-10
    Average 90 stars, based on 1 article reviews
    fragment libraries for massively parallel sequencing - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers
    Article Snippet: .. Using Illumina Massive Parallel Sequencing, we analyzed sRNA profiles from asymptomatic HTLV-1 and HTLV-2 infected individuals and healthy controls. ..

    Article Title: Autism-associated MDGA1 missense mutations impair distinct facets of central nervous system development
    Article Snippet: Libraries were prepared using KAPA Hyper plus Kit (Roche Diagnostics) following the manufacturer’s specifications and capture enrichment protocol with specific probes (KAPA HyperExome; Roche Diagnostics). .. Then, we perform subsequent massive parallel sequencing in a NextSeq550 equipment (Illumina). ..

    Article Title: The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes
    Article Snippet: .. This resulted in a 12.9 kb amplicon, which was subsequently subjected to massive parallel sequencing using the Illumina platform. ..

    Article Title: Isolated methylmalonic acidemia in Mexico: Genotypic spectrum, report of two novel MMUT variants and a possible synergistic heterozygosity effect
    Article Snippet: The genomic libraries were prepared using the Flex for Enrichment kit, and the exonic regions were captured using the TruSight One Expanded kit. .. The libraries were sequenced through massive parallel sequencing (paired-end 2 × 150 bp) using Illumina technology. ..

    Article Title: WIDESPREAD GEOGRAPHIC DISTRIBUTION OF FILARIOID NEMATODES IN CARIBOU (Rangifer tarandus sspp.) IN CANADA
    Article Snippet: .. In future, the suspected positive samples could be shot-gun sequenced (e.g., illumina massive parallel sequencing) or alternatively, other ddPCR panels specific to each filarioid known to infect Rangifer could be developed. ..

    Article Title: Case Report: Novel truncating PPM1D variant in a dichorionic diamniotic (DCDA) twin with Jansen-de Vries syndrome. an updated perspective
    Article Snippet: Libraries were then prepared using the KAPA Hyper Plus Kit (Roche Diagnostics) in accordance with the manufacturer’s specifications and capture enrichment protocol with specific probes (KAPA HyperExome; Roche Diagnostics). .. Subsequent to this, we undertook massive parallel sequencing on a NextSeq550 instrument (Illumina). ..

    Article Title: <i>BRCA</i> mutation in Vietnamese prostate cancer patients: a mixed cross-sectional study and case series
    Article Snippet: .. Massive parallel sequencing was performed using an Illumina MiSeq system (Illumina, USA) with a minimum target coverage of 100×. ..

    Article Title: Benchmarking bacterial taxonomic classification using nanopore metagenomics data of several mock communities
    Article Snippet: The most commonly used sequencing technology currently is Illumina, a second-generation sequencing technology. .. While Illumina provides massive parallel sequencing and a low error rate, it can typically only produce reads of lengths 100–300 bp. ..

    Infection:

    Article Title: HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers
    Article Snippet: .. Using Illumina Massive Parallel Sequencing, we analyzed sRNA profiles from asymptomatic HTLV-1 and HTLV-2 infected individuals and healthy controls. ..

    Amplification:

    Article Title: The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes
    Article Snippet: .. This resulted in a 12.9 kb amplicon, which was subsequently subjected to massive parallel sequencing using the Illumina platform. ..



    Similar Products

    99
    Complete Genomics Inc massive parallel sequencing
    Genetic and clinical summary of KBG syndrome. Genetic findings (left panel) showing variant characteristics (c.1977C>G; p.Tyr659Ter), American College of Medical Genetics and Genomics classification (PVS1, PM2, PP5), <t>sequencing</t> methodology and ANKRD11 protein structure with functional domains. The schematic illustrates the location of the truncating variant at position 659, resulting in loss of 75% of the protein including the repression domain, activation domain and C-terminal region. Clinical summary (right panel) consolidating developmental milestones, growth parameters, clinical features across multiple systems, key investigations and management outcomes after 24 months of follow-up. RD = repression domain; AD = activation domain .
    Massive Parallel Sequencing, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/DNBSEQ-G400/pmc12969402-32-0-9
    Average 99 stars, based on 1 article reviews
    massive parallel sequencing - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    86
    Novogene massive parallel sequencing
    A) Scheme showing the functional domains of p53, with the location of CASM34 mutants indicated in the zoomed-in panel. Transactivation (TAD) domain; proline-rich domain (PRD); DNA binding domain (DBD); oligomerization domain (OD); C-terminal domain (CTD). B and C) . Circular plots showing the base-pairing potentials of the p53 mRNA coding <t>sequence</t> (CDS) based on SHAPE reactivity with (B) p53-WT and (C) CASM34 (c.102 C>A) expressed in p53 null H1299 cells. Base-pairing across the nucleotides are indicated by lines and modifications in the lining pattern indicate RNA secondary structure alterations. RNA Regions which are significantly modified in secondary structure in CASM34 are indicated with dashed orange oval. D) and E) Secondary structures of indicated p53 mRNAs coding sequences using the SuperFold algorithm based on SHAPE values. SHAPE modified nucleotide sequences are indicated in orange and red. F) ΔSHAPE analysis demonstrates significant structural variations in the p53 mRNA CDS between p53-WT and CASM34 (c.102 C>A) mutant, with RNA regions constrained in CASM34 (c.102 C>A) are highlighted in green and the regions opened or exposed highlighted in violet. G) Same as (D) and (E) based on SHAPE values with CASM34 (c.102 C>G) mutant. SHAPE-Map data shown are representative of at least two independent repeats. RNA secondary structure models of p53-WT, showed in B) and D)are extracted from
    Massive Parallel Sequencing, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/massive+parallel+sequencing/bio_rxiv__64898__2026__01__26__701754-62-10-13
    Average 86 stars, based on 1 article reviews
    massive parallel sequencing - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    90
    Illumina Inc fragment libraries for massively parallel sequencing
    A) Scheme showing the functional domains of p53, with the location of CASM34 mutants indicated in the zoomed-in panel. Transactivation (TAD) domain; proline-rich domain (PRD); DNA binding domain (DBD); oligomerization domain (OD); C-terminal domain (CTD). B and C) . Circular plots showing the base-pairing potentials of the p53 mRNA coding <t>sequence</t> (CDS) based on SHAPE reactivity with (B) p53-WT and (C) CASM34 (c.102 C>A) expressed in p53 null H1299 cells. Base-pairing across the nucleotides are indicated by lines and modifications in the lining pattern indicate RNA secondary structure alterations. RNA Regions which are significantly modified in secondary structure in CASM34 are indicated with dashed orange oval. D) and E) Secondary structures of indicated p53 mRNAs coding sequences using the SuperFold algorithm based on SHAPE values. SHAPE modified nucleotide sequences are indicated in orange and red. F) ΔSHAPE analysis demonstrates significant structural variations in the p53 mRNA CDS between p53-WT and CASM34 (c.102 C>A) mutant, with RNA regions constrained in CASM34 (c.102 C>A) are highlighted in green and the regions opened or exposed highlighted in violet. G) Same as (D) and (E) based on SHAPE values with CASM34 (c.102 C>G) mutant. SHAPE-Map data shown are representative of at least two independent repeats. RNA secondary structure models of p53-WT, showed in B) and D)are extracted from
    Fragment Libraries For Massively Parallel Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/illumina+short+fragment+sequencing/pm40644351-56-0-10
    Average 90 stars, based on 1 article reviews
    fragment libraries for massively parallel sequencing - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    99
    Illumina Inc massive parallel sequencing
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Massive Parallel Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/NextSeq+550+Sequencing+System/pmc12235261-163-5-12
    Average 99 stars, based on 1 article reviews
    massive parallel sequencing - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    Illumina Inc whole-genome massively parallel sequencing
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Whole Genome Massively Parallel Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/miseq+platform/pm40537289-19-3-8
    Average 90 stars, based on 1 article reviews
    whole-genome massively parallel sequencing - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc massively parallel dna sequencing platforms
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Massively Parallel Dna Sequencing Platforms, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/dna+sequencing/us12331292-831-32-39
    Average 90 stars, based on 1 article reviews
    massively parallel dna sequencing platforms - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Novogene massive parallel amplicon sequencing
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Massive Parallel Amplicon Sequencing, supplied by Novogene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/amplicon+sequencing/pmc12167931-61-18-24
    Average 90 stars, based on 1 article reviews
    massive parallel amplicon sequencing - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    99
    Illumina Inc nonstranded rna seq massively parallel mrna sequencing approach
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Nonstranded Rna Seq Massively Parallel Mrna Sequencing Approach, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/TruSeq+RNA+Library+Preparation+Kit+v2/10__1523_slash_jneurosci__1789___24__2025-131-14-22
    Average 99 stars, based on 1 article reviews
    nonstranded rna seq massively parallel mrna sequencing approach - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    Nextera AS massive parallel sequencing nextera rapid capture
    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference <t>sequence</t> NM_003620.4 .
    Massive Parallel Sequencing Nextera Rapid Capture, supplied by Nextera AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massive+parallel+sequencing/nextera+sequencing/pmc12167554-57-16-24
    Average 90 stars, based on 1 article reviews
    massive parallel sequencing nextera rapid capture - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Genetic and clinical summary of KBG syndrome. Genetic findings (left panel) showing variant characteristics (c.1977C>G; p.Tyr659Ter), American College of Medical Genetics and Genomics classification (PVS1, PM2, PP5), sequencing methodology and ANKRD11 protein structure with functional domains. The schematic illustrates the location of the truncating variant at position 659, resulting in loss of 75% of the protein including the repression domain, activation domain and C-terminal region. Clinical summary (right panel) consolidating developmental milestones, growth parameters, clinical features across multiple systems, key investigations and management outcomes after 24 months of follow-up. RD = repression domain; AD = activation domain .

    Journal: Sultan Qaboos University Medical Journal

    Article Title: Novel ANKRD11 Mutation in KBG Syndrome: A diagnostic triad of hearing loss, radiological macrodontia and artificial intelligence-assisted facial phenotyping

    doi: 10.18295/2075-0528.2963

    Figure Lengend Snippet: Genetic and clinical summary of KBG syndrome. Genetic findings (left panel) showing variant characteristics (c.1977C>G; p.Tyr659Ter), American College of Medical Genetics and Genomics classification (PVS1, PM2, PP5), sequencing methodology and ANKRD11 protein structure with functional domains. The schematic illustrates the location of the truncating variant at position 659, resulting in loss of 75% of the protein including the repression domain, activation domain and C-terminal region. Clinical summary (right panel) consolidating developmental milestones, growth parameters, clinical features across multiple systems, key investigations and management outcomes after 24 months of follow-up. RD = repression domain; AD = activation domain .

    Article Snippet: Massive parallel sequencing was conducted on the DNBSEQ-G400 platform (MGI).

    Techniques: Variant Assay, Sequencing, Functional Assay, Activation Assay

    A) Scheme showing the functional domains of p53, with the location of CASM34 mutants indicated in the zoomed-in panel. Transactivation (TAD) domain; proline-rich domain (PRD); DNA binding domain (DBD); oligomerization domain (OD); C-terminal domain (CTD). B and C) . Circular plots showing the base-pairing potentials of the p53 mRNA coding sequence (CDS) based on SHAPE reactivity with (B) p53-WT and (C) CASM34 (c.102 C>A) expressed in p53 null H1299 cells. Base-pairing across the nucleotides are indicated by lines and modifications in the lining pattern indicate RNA secondary structure alterations. RNA Regions which are significantly modified in secondary structure in CASM34 are indicated with dashed orange oval. D) and E) Secondary structures of indicated p53 mRNAs coding sequences using the SuperFold algorithm based on SHAPE values. SHAPE modified nucleotide sequences are indicated in orange and red. F) ΔSHAPE analysis demonstrates significant structural variations in the p53 mRNA CDS between p53-WT and CASM34 (c.102 C>A) mutant, with RNA regions constrained in CASM34 (c.102 C>A) are highlighted in green and the regions opened or exposed highlighted in violet. G) Same as (D) and (E) based on SHAPE values with CASM34 (c.102 C>G) mutant. SHAPE-Map data shown are representative of at least two independent repeats. RNA secondary structure models of p53-WT, showed in B) and D)are extracted from

    Journal: bioRxiv

    Article Title: Cancer-associated synonymous mutations reveal stress signal-dependent mRNA folding that selectively modulates protein function

    doi: 10.64898/2026.01.26.701754

    Figure Lengend Snippet: A) Scheme showing the functional domains of p53, with the location of CASM34 mutants indicated in the zoomed-in panel. Transactivation (TAD) domain; proline-rich domain (PRD); DNA binding domain (DBD); oligomerization domain (OD); C-terminal domain (CTD). B and C) . Circular plots showing the base-pairing potentials of the p53 mRNA coding sequence (CDS) based on SHAPE reactivity with (B) p53-WT and (C) CASM34 (c.102 C>A) expressed in p53 null H1299 cells. Base-pairing across the nucleotides are indicated by lines and modifications in the lining pattern indicate RNA secondary structure alterations. RNA Regions which are significantly modified in secondary structure in CASM34 are indicated with dashed orange oval. D) and E) Secondary structures of indicated p53 mRNAs coding sequences using the SuperFold algorithm based on SHAPE values. SHAPE modified nucleotide sequences are indicated in orange and red. F) ΔSHAPE analysis demonstrates significant structural variations in the p53 mRNA CDS between p53-WT and CASM34 (c.102 C>A) mutant, with RNA regions constrained in CASM34 (c.102 C>A) are highlighted in green and the regions opened or exposed highlighted in violet. G) Same as (D) and (E) based on SHAPE values with CASM34 (c.102 C>G) mutant. SHAPE-Map data shown are representative of at least two independent repeats. RNA secondary structure models of p53-WT, showed in B) and D)are extracted from

    Article Snippet: RNAs were then subjected to polyA purification, library preparation and massive parallel sequencing (Novogene, UK).

    Techniques: Functional Assay, Binding Assay, Sequencing, Modification, Mutagenesis

    A) Volcano plot showing changes in expression levels of genome-wide transcripts in H1299 cells expressing p53-WT and CASM34 (c. 102 C>A) based on RNA-seq data of at least two independent replicates. B and C) Gene enrichment analysis of RNA-sequencing data categorizing the altered transcripts level following expression of p53-WT or CASM34 (c. 102 C>A) mRNAs.

    Journal: bioRxiv

    Article Title: Cancer-associated synonymous mutations reveal stress signal-dependent mRNA folding that selectively modulates protein function

    doi: 10.64898/2026.01.26.701754

    Figure Lengend Snippet: A) Volcano plot showing changes in expression levels of genome-wide transcripts in H1299 cells expressing p53-WT and CASM34 (c. 102 C>A) based on RNA-seq data of at least two independent replicates. B and C) Gene enrichment analysis of RNA-sequencing data categorizing the altered transcripts level following expression of p53-WT or CASM34 (c. 102 C>A) mRNAs.

    Article Snippet: RNAs were then subjected to polyA purification, library preparation and massive parallel sequencing (Novogene, UK).

    Techniques: Expressing, Genome Wide, RNA Sequencing

    PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference sequence NM_003620.4 .

    Journal: Frontiers in Genetics

    Article Title: Case Report: Novel truncating PPM1D variant in a dichorionic diamniotic (DCDA) twin with Jansen-de Vries syndrome. an updated perspective

    doi: 10.3389/fgene.2025.1601752

    Figure Lengend Snippet: PPM1D variants associated with Jansen-de Vries syndrome reported in the literature, in this case (red square), and in the ClinVar database to date ( https://www.ncbi.nlm.nih.gov/clinvar/ ). [1] ; [2] ; [3] ; [4] ; [5] ; [6] ; [7] ; [8] ; [9] ; [10] ; [11] ; [12] ; [13] ClinVar . Reference sequence NM_003620.4 .

    Article Snippet: Subsequent to this, we undertook massive parallel sequencing on a NextSeq550 instrument (Illumina).

    Techniques: Sequencing